SpeakersAgendaWhy attendPartnersVenue
Locations ā–¼

Request an invite

Partner with us

Request to partner

Request your invite

Call to action
Your text goes here. Insert your content, thoughts, or information in this space.
Button

Back to speakers

Fabien
Vial
VP, FP&A
uniQure
Fabien is a Boston-based global finance executive with 20+ years of experience across private and public companies in the biotech and life sciences sector. He currently serves as VP, Head of FP&A at uniQure, a gene therapy biotech, with prior executive finance leadership experience at Shire, Alexion, and Enzyvant across France, the UK, Switzerland, and the US, bringing deep expertise in financial planning and strategy for rare disease and biotech organizations. Fabien has built his career navigating the financial complexities of clinical-to-commercial stage biotechs. Fluent in French and English, with good knowledge of German, he has worked across global markets including the US, EU, CEE, MENA, Asia, and LATAM. Beyond his executive role, Fabien is active in patient advocacy, supporting families affected by rare diseases through his involvement with nonprofit organizations. He is known for combining rigorous financial leadership with a strong sense of purpose and community engagement.
Button
29 October 2027 13:15 - 14:00
Moderated roundtable discussions
4 discussions will run in parallel, each focused on a challenge CFOs are actively navigating right now. Choose the table most relevant to you and join a candid, peer-led conversation with CFOs facing the same pressure and trade-offs. Each table is moderated by a senior finance leader to keep the discussion grounded, practical, and relevant, with no presentations and no passive listening. Come prepared to challenge assumptions, compare approaches, and share what is actually working in your organisation. A snapshot of this yearā€™s roundtable themes: - Conviction and capital: where CFOs are actually placing bets right now (and where they're quietly pulling back) - The skills nobody budgeted for: what CFOs are actually hiring for now - Where the line still holds: what CFOs won't hand to AI, even now - Sounding sure when you're not: how CFOs actually talk to the board mid-uncertainty Connect with peers carrying the same accountability, benchmark decisions candidly, and leave with perspectives you can apply immediately in your own organisation.
29 October 2027 09:05 - 09:35
From R&D to commercial: How FP&A is critical to a successful transition
As organizations evolve from research-driven innovation to commercial growth, the role of FP&A becomes increasingly strategic. This session explores how finance can act as the bridge between scientific ambition and commercial success, providing the insights, and decision support needed to scale effectively. Whether your organization is preparing for commercialization or navigating rapid growth, this keynote will provide practical lessons on how FP&A can become a trusted strategic partner, enabling a successful transition from innovation to sustainable, profitable growth. Key takeaways: - Align financial strategy with commercial growth by building planning and forecasting processes that support the transition from R&D investment to revenue generation. - Make smarter capital allocation decisions by balancing long-term innovation with short-term commercial priorities and finite resources. - Position FP&A as a strategic business partner by enabling cross-functional decision-making, and supporting sustainable, profitable growth.